Molecular simulation of HER2/neu degradation by inhibiting HSP90

被引:30
作者
Chen, Calvin Yu-Chian [1 ]
Chen, Guan-Wen [1 ]
Chen, Winston Yu-Chen [1 ]
机构
[1] China Med Univ, Dept Biol Sci & Technol, Taichung 40404, Taiwan
关键词
HSP90; HER2/neu (ErbB-2); luteolin; docking; molecular simulation; flavonoid; 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1);
D O I
10.1002/jccs.200800044
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Several flavonoids were investigated for the degradation of the HER2/neu (ErbB-2), while the mechanism is still unknown. A hypothesis was generated here that the inhibition of HER2/neu expression was blocked by heat shock protein 90 alpha (HSP90 alpha) through 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) derivatives and flavonoids. In order to ensure the accuracy of the simulated protein structure, the RMSD value between the ligand in crystal structure from PDB and the ligand docking into HSP90 alpha was 1.13 angstrom. By molecular simulation, the flavonoids and YC-1 derivatives were employed to dock into HSP90 alpha. The results showed a good correlation between the evaluation scores of the flavonoids/HSP90 alpha complexes and the IC50 of flavonoids-induced degradation of HER2/neu. The YC-1 derivatives showed higher score values and lower interaction energies on average. Especially, the CLC107 got the highest rank in Potential of Mean Force (PMF) and Dock Score. Luteolin showed the highest dock score and quercetin had the lowest interaction energy of all flavonoid derivatives. This study investigated that the YC-1 derivatives and the flavonoids may be potent inhibitors for HSP90 alpha in antitumor strategies.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 28 条
[1]  
Batori M, 2006, Eur Rev Med Pharmacol Sci, V10, P51
[2]   Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2) [J].
Belen Granado-Serrano, Ana ;
Angeles Martin, Maria ;
Bravo, Laura ;
Goya, Luis ;
Ramos, Sonia .
JOURNAL OF NUTRITION, 2006, 136 (11) :2715-2721
[3]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[4]   Heat shock proteins in cancer: chaperones of tumorigenesis [J].
Calderwood, SK ;
Khaleque, MA ;
Sawyer, DB ;
Ciocca, DR .
TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (03) :164-172
[5]   HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab - a case report [J].
Church, D. N. ;
Bahl, A. ;
Jones, A. ;
Price, C. G. A. .
JOURNAL OF NEURO-ONCOLOGY, 2006, 79 (03) :289-292
[6]  
Citri A, 2004, CELL CYCLE, V3, P51
[7]   Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells [J].
Deguchi, A ;
Xing, SW ;
Shureiqi, I ;
Yang, PY ;
Newman, RA ;
Lippman, SM ;
Feinmark, SJ ;
Oehlen, B ;
Weinstein, IB .
CANCER RESEARCH, 2005, 65 (18) :8442-8447
[8]   Flavonoids from the flowers of Pueraria lobata [J].
Ding, HY ;
Chen, YY ;
Chang, WL ;
Lin, HC .
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2004, 51 (06) :1425-1428
[9]   Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design [J].
Dymock, BW ;
Barril, X ;
Brough, PA ;
Cansfield, JE ;
Massey, A ;
McDonald, E ;
Hubbard, RE ;
Surgenor, A ;
Roughley, SD ;
Webb, P ;
Workman, P ;
Wright, L ;
Drysdale, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4212-4215
[10]   MOLECULAR RECOGNITION OF THE INHIBITOR AG-1343 BY HIV-1 PROTEASE - CONFORMATIONALLY FLEXIBLE DOCKING BY EVOLUTIONARY PROGRAMMING [J].
GEHLHAAR, DK ;
VERKHIVKER, GM ;
REJTO, PA ;
SHERMAN, CJ ;
FOGEL, DB ;
FOGEL, LJ ;
FREER, ST .
CHEMISTRY & BIOLOGY, 1995, 2 (05) :317-324